NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SPIRE Therapeutics, Inc.

SPIRE Therapeutics, Inc.

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://spire.us/

Last Round

Accelerator

Aug 27, 2024

Company Overview

SPIRE Therapeutics, Inc. is a therapeutic devices company that develops noninvasive ultrasound-based neuromodulation technology for the treatment of neurological disorders such as chronic pain and depression.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

low-intensity focused ultrasoundLIFUultrasonic neuromodulationneuromodulationdeep brain therapyfocused ultrasoundFUStreatment-resistant depressionTRDchronic pain treatmentnoninvasive brain stimulationwearable medical deviceMedTechtranscranial ultrasounddrug-free therapyclinical stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPIRE Therapeutics, Inc. Comparables

Compare SPIRE Therapeutics, Inc. with similar companies based on industry and business-model similarity.

SPIRE Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Attune Neurosciences
87%
Openwater
81%
Neurosona
78%

SPIRE Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 27, 2024

Key People

Founding team and executive leadership

Tom Riis

Cofounder & CTO

Founding Team

SPIRE Therapeutics, Inc. Investors

Notable investors and investment history

SPIRE Therapeutics, Inc. investors
InvestorRounds
NIH RADxAccelerator
Altitude LabAccelerator
Wilson Sonsini Goodrich & RosatiAccelerator
Wellcome TrustAccelerator
National Science FoundationAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2024

    Led by Altitude Lab with participation from Focused Ultrasound Foundation.

SPIRE Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SPIRE Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SPIRE Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range3
Year Founded2023
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.